Epicardial adipose tissue is related to arterial stiffness and inflammation in patients with cardiovascular disease and type 2 diabetes
Authors:
- Shaween Al-TalabanySAShaween Al-Talabany
- Ify MordiIMIfy Mordi
- J. Graeme HoustonJHJ. Graeme Houston
- Helen M. ColhounHCHelen M. Colhoun
- Jonathan R. Weir-McCallJWJonathan R. Weir-McCall
- Shona Z. MatthewSMShona Z. Matthew
- Helen C. LookerHLHelen C. Looker
- Daniel LevinDLDaniel Levin
- Jill J. F. BelchJill J. F. Belch
- Fiona DoveFDFiona Dove
- Faisel KhanFKFaisel Khan
- Chim C. LangCLChim C. Lang
Open Access
- 13 February 2018
- journal article
- research article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 18 (1) , 1-8
Abstract
Epicardial adipose tissue (EAT) is an emerging cardio-metabolic risk factor and has been shown to correlate with adverse cardiovascular (CV) outcome; however the underlying pathophysiology of this link is not well understood. The aim of this study was to evaluate the relationship between EAT and a comprehensive panel of cardiovascular risk biomarkers and pulse wave velocity (PWV) and indexed left ventricular mass (LVMI) in a cohort of patients with cardiovascular disease (CVD) and diabetes compared to controls. One hundred forty-five participants (mean age 63.9 ± 8.1 years; 61% male) were evaluated. All patients underwent cardiovascular magnetic resonance (CMR) examination and PWV. EAT measurements from CMR were performed on the 4-chamber view. Blood samples were taken and a range of CV biomarkers was evaluated. EAT measurements were significantly higher in the groups with CVD, with or without T2DM compared to patients without CVD or T2DM (group 1 EAT 15.9 ± 5.5 cm2 vs. group 4 EAT 11.8 ± 4.1 cm2, p = 0.001; group 3 EAT 15.1 ± 4.3 cm2 vs. group 4 EAT 11.8 ± 4.1 cm2, p = 0.024). EAT was independently associated with IL-6 (beta 0.2, p = 0.019). When added to clinical variables, both EAT (beta 0.16, p = 0.035) and IL-6 (beta 0.26, p = 0.003) were independently associated with PWV. EAT was significantly associated with LVMI in a univariable analysis but not when added to significant clinical variables. In patients with cardio-metabolic disease, EAT was independently associated with PWV. EAT may be associated with CVD risk due to an increase in systemic vascular inflammation. Whether targeting EAT may reduce inflammation and/or cardiovascular risk should be evaluated in prospective studies.Keywords
Funding Information
- FP7 Ideas: European Research Council
- Chief Scientist Office (PCL 17/07)
- Wellcome Trust (WT085664)
This publication has 37 references indexed in Scilit:
- Cohort comparison study of cardiac disease and atherosclerotic burden in type 2 diabetic adults using whole body cardiovascular magnetic resonance imagingCardiovascular Diabetology, 2015
- Local and systemic effects of the multifaceted epicardial adipose tissue depotNature Reviews Endocrinology, 2015
- Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thicknessAtherosclerosis, 2014
- Body Fat Distribution, Incident Cardiovascular Disease, Cancer, and All-Cause MortalityJACC, 2013
- Echocardiographic epicardial fat thickness is associated with arterial stiffnessInternational Journal of Cardiology, 2013
- Association of Epicardial Fat With Cardiovascular Risk Factors and Incident Myocardial Infarction in the General PopulationJACC, 2013
- Cardiac Steatosis Associates With Visceral Obesity in Nondiabetic Obese MenThe Journal of Clinical Endocrinology & Metabolism, 2013
- CD40L induces inflammation and adipogenesis in adipose cells – a potential link between metabolic and cardiovascular diseaseThrombosis and Haemostasis, 2010
- Epicardial adipose tissue imaged by magnetic resonance imaging: an important risk marker of cardiovascular diseaseHeart, 2006
- Inflammation as a Cardiovascular Risk FactorCirculation, 2004